Reported Earnings • May 06
First quarter 2026 earnings released: US$0.01 loss per share (vs US$0.01 loss in 1Q 2025) First quarter 2026 results: US$0.01 loss per share (in line with 1Q 2025). Revenue: US$3.77m (down 6.6% from 1Q 2025). Net loss: US$592.1k (loss narrowed 2.4% from 1Q 2025). Over the last 3 years on average, earnings per share has increased by 56% per year but the company’s share price has remained flat, which means it is significantly lagging earnings. Duyuru • Apr 23
EcoSynthetix Inc. to Report Q1, 2026 Results on May 05, 2026 EcoSynthetix Inc. announced that they will report Q1, 2026 results at 5:00 PM, US Eastern Standard Time on May 05, 2026 Duyuru • Mar 10
EcoSynthetix Inc., Annual General Meeting, May 21, 2026 EcoSynthetix Inc., Annual General Meeting, May 21, 2026. Reported Earnings • Feb 21
Full year 2025 earnings released: US$0.007 loss per share (vs US$0.023 loss in FY 2024) Full year 2025 results: US$0.007 loss per share (improved from US$0.023 loss in FY 2024). Revenue: US$20.8m (up 12% from FY 2024). Net loss: US$433.8k (loss narrowed 68% from FY 2024). Over the last 3 years on average, earnings per share has increased by 45% per year but the company’s share price has fallen by 1% per year, which means it is significantly lagging earnings. Duyuru • Feb 11
EcoSynthetix Inc. to Report Q4, 2025 Results on Feb 19, 2026 EcoSynthetix Inc. announced that they will report Q4, 2025 results at 5:00 PM, US Eastern Standard Time on Feb 19, 2026 New Risk • Jan 11
New minor risk - Insider selling There has been significant insider selling in the company's shares over the past 3 months. Total value of shares sold: €1.3m This is considered a minor risk. There are several reasons why an insider may be selling, including to cover a tax obligation or pay for some other expense. However, we generally consider it a negative if insiders have been selling, especially if they do so below the current price. It implies that they considered a lower price to be reasonable. This is a weak signal, but if there is a pattern of unexplained selling, it can be a sign the insider believes the company's stock is overpriced. Note: We only include open market transactions and private dispositions of directly owned stock by individuals, not by corporations or trusts. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (7.8% average weekly change). Significant insider selling over the past 3 months (€1.3m sold). Recent Insider Transactions • Jan 11
CEO & Director recently sold €436k worth of stock On the 7th of January, Jeffrey MacDonald sold around 176k shares on-market at roughly €2.48 per share. This transaction amounted to 12% of their direct individual holding at the time of the trade. This was the largest sale by an insider in the last 3 months. Jeffrey has been a net seller over the last 12 months, reducing personal holdings by €180k. New Risk • Dec 29
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of German stocks, typically moving 7.8% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. This is currently the only risk that has been identified for the company. Reported Earnings • Nov 09
Third quarter 2025 earnings released: US$0.002 loss per share (vs US$0.002 profit in 3Q 2024) Third quarter 2025 results: US$0.002 loss per share (down from US$0.002 profit in 3Q 2024). Revenue: US$5.83m (up 12% from 3Q 2024). Net loss: US$91.0k (down 164% from profit in 3Q 2024). Over the last 3 years on average, earnings per share has increased by 36% per year but the company’s share price has fallen by 4% per year, which means it is significantly lagging earnings. Duyuru • Oct 24
EcoSynthetix Inc. to Report Q3, 2025 Results on Nov 06, 2025 EcoSynthetix Inc. announced that they will report Q3, 2025 results at 5:00 PM, US Eastern Standard Time on Nov 06, 2025 Reported Earnings • Jul 30
Second quarter 2025 earnings released: EPS: US$0.002 (vs US$0.012 loss in 2Q 2024) Second quarter 2025 results: EPS: US$0.002 (up from US$0.012 loss in 2Q 2024). Revenue: US$5.00m (up 57% from 2Q 2024). Net income: US$111.0k (up US$794.9k from 2Q 2024). Profit margin: 2.2% (up from net loss in 2Q 2024). The move to profitability was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 30% per year but the company’s share price has fallen by 5% per year, which means it is significantly lagging earnings. Duyuru • Jul 17
EcoSynthetix Inc. to Report Q2, 2025 Results on Jul 29, 2025 EcoSynthetix Inc. announced that they will report Q2, 2025 results at 5:00 PM, Eastern Standard Time on Jul 29, 2025 Reported Earnings • May 10
First quarter 2025 earnings released: US$0.01 loss per share (vs US$0.011 loss in 1Q 2024) First quarter 2025 results: US$0.01 loss per share (improved from US$0.011 loss in 1Q 2024). Revenue: US$4.04m (down 14% from 1Q 2024). Net loss: US$606.5k (loss narrowed 2.1% from 1Q 2024). Over the last 3 years on average, earnings per share has increased by 22% per year but the company’s share price has fallen by 13% per year, which means it is significantly lagging earnings. Duyuru • Apr 30
EcoSynthetix Inc. to Report Q1, 2025 Results on May 08, 2025 EcoSynthetix Inc. announced that they will report Q1, 2025 results at 5:00 PM, US Eastern Standard Time on May 08, 2025 Duyuru • Mar 11
EcoSynthetix Inc., Annual General Meeting, May 22, 2025 EcoSynthetix Inc., Annual General Meeting, May 22, 2025. Reported Earnings • Feb 20
Full year 2024 earnings released: US$0.023 loss per share (vs US$0.048 loss in FY 2023) Full year 2024 results: US$0.023 loss per share (improved from US$0.048 loss in FY 2023). Revenue: US$18.5m (up 46% from FY 2023). Net loss: US$1.37m (loss narrowed 52% from FY 2023). Over the last 3 years on average, earnings per share has increased by 18% per year but the company’s share price has fallen by 4% per year, which means it is significantly lagging earnings. Duyuru • Feb 06
EcoSynthetix Inc. to Report Q4, 2024 Results on Feb 19, 2025 EcoSynthetix Inc. announced that they will report Q4, 2024 results at 5:00 PM, US Eastern Standard Time on Feb 19, 2025 Reported Earnings • Nov 05
Third quarter 2024 earnings released: EPS: US$0.002 (vs US$0.005 loss in 3Q 2023) Third quarter 2024 results: EPS: US$0.002 (up from US$0.005 loss in 3Q 2023). Revenue: US$5.23m (up 38% from 3Q 2023). Net income: US$143.2k (up US$411.1k from 3Q 2023). Profit margin: 2.7% (up from net loss in 3Q 2023). Over the last 3 years on average, earnings per share has increased by 13% per year but the company’s share price has fallen by 9% per year, which means it is significantly lagging earnings. Duyuru • Oct 23
EcoSynthetix Inc. to Report Q3, 2024 Results on Nov 04, 2024 EcoSynthetix Inc. announced that they will report Q3, 2024 results at 5:00 PM, US Eastern Standard Time on Nov 04, 2024 Board Change • Aug 01
Insufficient new directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 2 experienced directors. 3 highly experienced directors. Independent Director Sara Elford was the last director to join the board, commencing their role in 2021. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model. Reported Earnings • Jul 31
Second quarter 2024 earnings released: US$0.012 loss per share (vs US$0.017 loss in 2Q 2023) Second quarter 2024 results: US$0.012 loss per share (improved from US$0.017 loss in 2Q 2023). Revenue: US$3.18m (up 7.8% from 2Q 2023). Net loss: US$683.9k (loss narrowed 30% from 2Q 2023). Over the last 3 years on average, earnings per share has increased by 8% per year but the company’s share price has fallen by 10% per year, which means it is significantly lagging earnings. Duyuru • Jul 19
EcoSynthetix Inc. to Report Q2, 2024 Results on Jul 30, 2024 EcoSynthetix Inc. announced that they will report Q2, 2024 results at 5:00 PM, US Eastern Standard Time on Jul 30, 2024 Recent Insider Transactions • May 16
Chief Financial Officer recently sold €364k worth of stock On the 14th of May, Robert Haire sold around 119k shares on-market at roughly €3.05 per share. This transaction amounted to 43% of their direct individual holding at the time of the trade. This was the largest sale by an insider in the last 3 months. Robert has been a net seller over the last 12 months, reducing personal holdings by €438k. Reported Earnings • May 07
First quarter 2024 earnings released: US$0.011 loss per share (vs US$0.017 loss in 1Q 2023) First quarter 2024 results: US$0.011 loss per share (improved from US$0.017 loss in 1Q 2023). Revenue: US$4.69m (up 53% from 1Q 2023). Net loss: US$619.3k (loss narrowed 37% from 1Q 2023). Over the last 3 years on average, earnings per share has increased by 4% per year but the company’s share price has fallen by 3% per year, which means it is significantly lagging earnings. Duyuru • Apr 24
EcoSynthetix Inc. to Report Q1, 2024 Results on May 06, 2024 EcoSynthetix Inc. announced that they will report Q1, 2024 results at 5:00 PM, US Eastern Standard Time on May 06, 2024 Duyuru • Mar 01
EcoSynthetix Inc., Annual General Meeting, May 14, 2024 EcoSynthetix Inc., Annual General Meeting, May 14, 2024. Reported Earnings • Feb 29
Full year 2023 earnings released: US$0.048 loss per share (vs US$0.04 loss in FY 2022) Full year 2023 results: US$0.048 loss per share (further deteriorated from US$0.04 loss in FY 2022). Revenue: US$12.7m (down 34% from FY 2022). Net loss: US$2.82m (loss widened 19% from FY 2022). Over the last 3 years on average, earnings per share has remained flat whereas the company’s share price has increased by 5% per year. New Risk • Feb 29
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of German stocks, typically moving 7.0% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 8.8% per year over the past 5 years. Minor Risk Share price has been volatile over the past 3 months (7.0% average weekly change). Duyuru • Feb 15
EcoSynthetix Inc. to Report Q4, 2023 Results on Feb 27, 2024 EcoSynthetix Inc. announced that they will report Q4, 2023 results at 5:00 PM, Eastern Standard Time on Feb 27, 2024 Recent Insider Transactions • Nov 18
CEO & Director recently sold €231k worth of stock On the 14th of November, Jeffrey MacDonald sold around 104k shares on-market at roughly €2.22 per share. This transaction amounted to 8.4% of their direct individual holding at the time of the trade. This was the largest sale by an insider in the last 3 months. Jeffrey has been a net seller over the last 12 months, reducing personal holdings by €515k. Reported Earnings • Nov 03
Third quarter 2023 earnings released: US$0.005 loss per share (vs US$0.007 loss in 3Q 2022) Third quarter 2023 results: US$0.005 loss per share (improved from US$0.007 loss in 3Q 2022). Revenue: US$3.80m (down 24% from 3Q 2022). Net loss: US$267.9k (loss narrowed 31% from 3Q 2022). Over the last 3 years on average, earnings per share has fallen by 2% per year but the company’s share price has increased by 9% per year, which means it is well ahead of earnings. Duyuru • Oct 21
EcoSynthetix Inc. to Report Q3, 2023 Results on Nov 02, 2023 EcoSynthetix Inc. announced that they will report Q3, 2023 results at 5:00 PM, US Eastern Standard Time on Nov 02, 2023 New Risk • Aug 04
New major risk - Revenue and earnings growth Earnings have declined by 2.9% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 2.9% per year over the past 5 years. Minor Risk Share price has been volatile over the past 3 months (7.3% average weekly change). Reported Earnings • Aug 03
Second quarter 2023 earnings released: US$0.017 loss per share (vs US$0.011 loss in 2Q 2022) Second quarter 2023 results: US$0.017 loss per share (further deteriorated from US$0.011 loss in 2Q 2022). Revenue: US$2.95m (down 29% from 2Q 2022). Net loss: US$980.2k (loss widened 45% from 2Q 2022). Over the last 3 years on average, earnings per share has fallen by 6% per year but the company’s share price has increased by 20% per year, which means it is well ahead of earnings. Duyuru • Jul 23
EcoSynthetix Inc. to Report Q2, 2023 Results on Aug 02, 2023 EcoSynthetix Inc. announced that they will report Q2, 2023 results at 5:00 PM, US Eastern Standard Time on Aug 02, 2023 New Risk • Jul 03
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of German stocks, typically moving 6.7% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. This is currently the only risk that has been identified for the company. Reported Earnings • May 07
First quarter 2023 earnings released: US$0.017 loss per share (vs US$0.011 loss in 1Q 2022) First quarter 2023 results: US$0.017 loss per share (further deteriorated from US$0.011 loss in 1Q 2022). Revenue: US$3.06m (down 28% from 1Q 2022). Net loss: US$988.3k (loss widened 50% from 1Q 2022). Over the last 3 years on average, earnings per share has fallen by 11% per year but the company’s share price has increased by 16% per year, which means it is well ahead of earnings. Reported Earnings • Mar 03
Full year 2022 earnings released: US$0.04 loss per share (vs US$0.055 loss in FY 2021) Full year 2022 results: US$0.04 loss per share (improved from US$0.055 loss in FY 2021). Revenue: US$19.0m (up 4.8% from FY 2021). Net loss: US$2.38m (loss narrowed 25% from FY 2021). Over the last 3 years on average, earnings per share has fallen by 17% per year but the company’s share price has increased by 20% per year, which means it is well ahead of earnings. Recent Insider Transactions • Dec 01
CEO & Director recently sold €438k worth of stock On the 25th of November, Jeffrey MacDonald sold around 160k shares on-market at roughly €2.73 per share. This transaction amounted to 13% of their direct individual holding at the time of the trade. This was the largest sale by an insider in the last 3 months. This was Jeffrey's only on-market trade for the last 12 months. Reported Earnings • Nov 04
Third quarter 2022 earnings released: US$0.007 loss per share (vs US$0.013 loss in 3Q 2021) Third quarter 2022 results: US$0.007 loss per share (improved from US$0.013 loss in 3Q 2021). Revenue: US$5.02m (up 6.7% from 3Q 2021). Net loss: US$388.9k (loss narrowed 49% from 3Q 2021). Revenue is forecast to grow 54% p.a. on average during the next 3 years, while revenues in the Chemicals industry in Germany are expected to remain flat. Over the last 3 years on average, earnings per share has fallen by 26% per year but the company’s share price has increased by 16% per year, which means it is well ahead of earnings. Reported Earnings • Aug 10
Second quarter 2022 earnings released: US$0.011 loss per share (vs US$0.013 loss in 2Q 2021) Second quarter 2022 results: US$0.011 loss per share (up from US$0.013 loss in 2Q 2021). Revenue: US$4.17m (down 15% from 2Q 2021). Net loss: US$676.8k (loss narrowed 7.2% from 2Q 2021). Over the next year, revenue is forecast to grow 128%, compared to a 3.6% growth forecast for the industry in Germany. Over the last 3 years on average, earnings per share has fallen by 32% per year but the company’s share price has increased by 26% per year, which means it is well ahead of earnings. Reported Earnings • May 05
First quarter 2022 earnings released: US$0.011 loss per share (vs US$0.013 loss in 1Q 2021) First quarter 2022 results: US$0.011 loss per share (up from US$0.013 loss in 1Q 2021). Revenue: US$4.24m (up 15% from 1Q 2021). Net loss: US$658.9k (loss narrowed 12% from 1Q 2021). Over the next year, revenue is forecast to grow 72%, compared to a 8.5% growth forecast for the industry in Germany. Over the last 3 years on average, earnings per share has fallen by 33% per year but the company’s share price has increased by 47% per year, which means it is well ahead of earnings. Reported Earnings • Feb 26
Full year 2021 earnings: EPS in line with analyst expectations despite revenue beat Full year 2021 results: US$0.055 loss per share (down from US$0.042 loss in FY 2020). Revenue: US$18.2m (up 33% from FY 2020). Net loss: US$3.18m (loss widened 32% from FY 2020). Revenue exceeded analyst estimates by 3.1%. Over the next year, revenue is forecast to grow 46%, compared to a 6.7% growth forecast for the industry in Germany. Over the last 3 years on average, earnings per share has fallen by 26% per year but the company’s share price has increased by 41% per year, which means it is well ahead of earnings. Recent Insider Transactions • Dec 02
CEO & Director recently sold €3.1m worth of stock On the 26th of November, Jeffrey MacDonald sold around 800k shares on-market at roughly €3.86 per share. This was the largest sale by an insider in the last 3 months. This was Jeffrey's only on-market trade for the last 12 months. Reported Earnings • Nov 06
Third quarter 2021 earnings released: US$0.013 loss per share (vs US$0.011 loss in 3Q 2020) The company reported a solid third quarter result with improved revenues and control over costs, although losses increased. Third quarter 2021 results: Revenue: US$4.71m (up 57% from 3Q 2020). Net loss: US$763.9k (loss widened 19% from 3Q 2020). Over the last 3 years on average, earnings per share has fallen by 10% per year but the company’s share price has increased by 46% per year, which means it is well ahead of earnings. Reported Earnings • Jul 30
Second quarter 2021 earnings released: US$0.013 loss per share (vs US$0.011 loss in 2Q 2020) The company reported a solid second quarter result with improved revenues and control over costs, although losses increased. Second quarter 2021 results: Revenue: US$4.90m (up 58% from 2Q 2020). Net loss: US$729.1k (loss widened 20% from 2Q 2020). Over the last 3 years on average, earnings per share has increased by 10% per year but the company’s share price has increased by 51% per year, which means it is tracking significantly ahead of earnings growth. Executive Departure • May 31
Independent Director has left the company On the 25th of May, Martin Hubbes' tenure as Independent Director ended after 4.4 years in the role. As of March 2021, Martin personally held 164.50k shares (€474k worth at the time). Martin is the only executive to leave the company over the last 12 months. Reported Earnings • May 05
First quarter 2021 earnings released: US$0.013 loss per share (vs US$0.008 loss in 1Q 2020) The company reported a poor first quarter result with increased losses, weaker revenues and weaker control over costs. First quarter 2021 results: Revenue: US$3.67m (down 13% from 1Q 2020). Net loss: US$749.9k (loss widened 68% from 1Q 2020). Over the last 3 years on average, earnings per share has increased by 30% per year but the company’s share price has increased by 39% per year, which means it is tracking significantly ahead of earnings growth. Reported Earnings • Mar 05
Full year 2020 earnings released: US$0.042 loss per share (vs US$0.025 loss in FY 2019) The company reported a poor full year result with increased losses, weaker revenues and weaker control over costs. Full year 2020 results: Revenue: US$13.7m (down 26% from FY 2019). Net loss: US$2.40m (loss widened 65% from FY 2019). Over the last 3 years on average, earnings per share has increased by 46% per year but the company’s share price has only increased by 34% per year, which means it is significantly lagging earnings growth. Is New 90 Day High Low • Jan 30
New 90-day high: €3.12 The company is up 85% from its price of €1.69 on 30 October 2020. The German market is up 18% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 28% over the same period. Is New 90 Day High Low • Jan 14
New 90-day high: €2.58 The company is up 51% from its price of €1.71 on 15 October 2020. The German market is up 8.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 17% over the same period. Recent Insider Transactions • Jan 03
CFO & Corporate Secretary recently sold €394k worth of stock On the 31st of December, Robert Haire sold around 169k shares on-market at roughly €2.33 per share. This was the largest sale by an insider in the last 3 months. Robert has been a seller over the last 12 months, reducing personal holdings by €738k. Is New 90 Day High Low • Dec 24
New 90-day high: €2.10 The company is up 51% from its price of €1.39 on 24 September 2020. The German market is up 9.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 20% over the same period. Recent Insider Transactions • Nov 14
CFO & Corporate Secretary recently sold €345k worth of stock On the 9th of November, Robert Haire sold around 175k shares on-market at roughly €1.97 per share. This was the largest sale by an insider in the last 3 months. This was Robert's only on-market trade for the last 12 months. Is New 90 Day High Low • Nov 11
New 90-day high: €1.94 The company is up 34% from its price of €1.45 on 12 August 2020. The German market is flat over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 5.0% over the same period. Reported Earnings • Nov 06
Third quarter 2020 earnings released: US$0.011 loss per share The company reported a poor third quarter result with increased losses and weaker revenues and control over expenses. Third quarter 2020 results: Revenue: US$2.99m (down 34% from 3Q 2019). Net loss: US$640.7k (loss widened 105% from 3Q 2019). Is New 90 Day High Low • Oct 07
New 90-day high: €1.51 The company is up 9.0% from its price of €1.39 on 09 July 2020. The German market is up 3.0% over the last 90 days, indicating the company outperformed over that time. However, it underperformed the Chemicals industry, which is up 10.0% over the same period.